Načítá se...
Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a post mortem study
Natalizumab, a monoclonal antibody directed against α4 integrins, has to date been associated with 377 cases of progressive multifocal leukoencephalopathy (PML) worldwide in patients receiving treatment for multiple sclerosis (MS). Due to the limited number of histological studies, the interplay bet...
Uloženo v:
| Vydáno v: | J Neuropathol Exp Neurol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4465443/ https://ncbi.nlm.nih.gov/pubmed/24128680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/NEN.0000000000000005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|